ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 393,76
0,18%
Dow Jones
42 213,27
-0,78%
DAX
20 024,66
0,58%
Brent Oil
75,875
2,74%
Bitcoin
96 770,03
2,52%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX

  6. Eagle Capital Growth Fund Inc (GRF) Cours

Eagle Capital Growth Fund Inc

Eagle Capital Growth Fund Inc (GRF)

Greiffenberger AG
Green Rise Foods Inc
9,75
0,00
( 0,00% )
Mis à jour : 17:53:35
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
9,75
Prix Achat
-
Prix Vente
-
Volume échangé
349
9,64 Fourchette du Jour 9,85
8,72 Plage de 52 semaines 10,99
Cap du marché
38,686M
Clôture Veille
9,75
Ouverture
9,64
Dernière Transaction
21
@
9.82
Dernière heure de transaction
17:53:35
Volume financier
US$ 3 418
VWAP
9,7924
Volume moyen (3 m)
6 731
Actions en circulation
3 967 836
Rendement du Dividende
6.97%
Ratio Cours sur Bénéfices
8,39
Bénéfice par action (BPA)
1,16
Chiffre d'affairess
736k
Bénéfice net
4,61M

À propos de Eagle Capital Growth Fund Inc

The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.

Secteur
Unit Inv Tr, Closed-end Mgmt
Industrie
Unit Inv Tr, Closed-end Mgmt
Siège social
Lutherville Timonium, Maryland, USA
Fondé
-
Eagle Capital Growth Fund Inc est coté dans le secteur Unit Inv Tr, Closed-end Mgmt de la American Stock Exchange avec le ticker GRF. Le dernier cours de clôture d'Eagle Capital Growth était de US$9,75. Au cours de la dernière année, les actions de Eagle Capital Growth ont été négociées dans une fourchette de prix de US$ 8,72 à US$ 10,99.

Eagle Capital Growth compte actuellement 3 967 836 actions en circulation. La capitalisation boursière d'Eagle Capital Growth est de US$38,69 million. Eagle Capital Growth a un ratio cours/bénéfice (ratio PE) de 8.39.

GRF Dernières nouvelles

Plus de nouvelles

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

26 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Décembre 2024
Edgar (US Regulatory)

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

19 Novembre 2024
GlobeNewswire Inc.

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024...

18 Novembre 2024
Business Wire

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

29 Octobre 2024
GlobeNewswire Inc.

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

22 Octobre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

03 Octobre 2024
Edgar (US Regulatory)

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

03 Octobre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Septembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Septembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.242.523659305999.5110.289.5115569.85676024CS
40.272.848101265829.4810.779.41137910.05689169CS
120.030.3086419753099.7210.998.8567319.97872272CS
260.394.166666666679.3610.998.8550139.82255101CS
520.141.456815816869.6110.998.7238799.63003122CS
1560.020.2055498458389.7311.257.846789.1739904CS
2601.5619.04761904768.1911.255.249608.55206648CS

GRF - Frequently Asked Questions (FAQ)

What is the current Eagle Capital Growth share price?
The current share price of Eagle Capital Growth is US$ 9,75
How many Eagle Capital Growth shares are in issue?
Eagle Capital Growth has 3 967 836 shares in issue
What is the market cap of Eagle Capital Growth?
The market capitalisation of Eagle Capital Growth is USD 38,69M
What is the 1 year trading range for Eagle Capital Growth share price?
Eagle Capital Growth has traded in the range of US$ 8,72 to US$ 10,99 during the past year
What is the PE ratio of Eagle Capital Growth?
The price to earnings ratio of Eagle Capital Growth is 8,39
What is the cash to sales ratio of Eagle Capital Growth?
The cash to sales ratio of Eagle Capital Growth is 52,56
What is the reporting currency for Eagle Capital Growth?
Eagle Capital Growth reports financial results in USD
What is the latest annual turnover for Eagle Capital Growth?
The latest annual turnover of Eagle Capital Growth is USD 736k
What is the latest annual profit for Eagle Capital Growth?
The latest annual profit of Eagle Capital Growth is USD 4,61M
What is the registered address of Eagle Capital Growth?
The registered address for Eagle Capital Growth is 2405 YORK ROAD, SUITE 201, LUTHERVILLE TIMONIUM, MARYLAND, 21093 2264
Which industry sector does Eagle Capital Growth operate in?
Eagle Capital Growth operates in the UNIT INV TR, CLOSED-END MGMT sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
KLIPKraneshares China Internet and Covered Call Strategy ETF
US$ 31,586
(191,92%)
119,78k
AMBOAmbow Education Holding Ltd
US$ 2,962
(41,05%)
185,47k
NCLNorthann Corp
US$ 0,3503
(28,50%)
1,19M
BURUNuburu Inc
US$ 0,80
(20,23%)
2,47M
GRFXGraphex Group Limited
US$ 0,33
(19,96%)
6,53M
LODEComstock Inc
US$ 0,6898
(-13,84%)
13,6M
TSLTT Rex 2X Long Tesla Daily Target ETF
US$ 32,6619
(-13,78%)
4,17M
IHTInnsuites Hospitality Trust
US$ 1,90
(-12,07%)
178
ROLRHigh Roller Technologies Inc
US$ 3,85
(-11,90%)
38,13k
KULRKULR Technology Group Inc
US$ 3,135
(-11,69%)
34,48M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,414
(2,13%)
81,61M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,8298
(13,65%)
66,37M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,37
(0,22%)
55,85M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3,2302
(-2,70%)
40,17M
OPTTOcean Power Technologies Inc
US$ 0,9439
(-7,46%)
37,94M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

AMEX
GRF
Eagle Capital Growth
BIT
UC6Y5K
Unicredit Bank
BIT
UC24CM
Unicredit Bank
BIT
UC5292
Unicredit Bank
BIT
UB51MR
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés